NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: R
Post# of 87
(Total Views: 653)
Posted On: 08/01/2019 4:59:19 PM
NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Health Canada Approval for Radicle’s Production Facility Expansion Project
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval effectively doubles Radicle’s production footprint, significantly increasing its yearly capacity to 6,000 kilograms. “We are thrilled with the continued growth happening at Radicle,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “The cannabis industry is showing many similarities to the craft beer movement, where local, artisanal operators are succeeding in securing loyal and robust customer followings. Radicle is thriving within this craft segment, and is raising the bar when it comes to its unique strains offered under the Gage brand. We see no slowdown in consumer demand for premium products and brands, and this Health Canada approval will help Radicle better supply high quality craft cannabis to both the medical and adult-use markets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval effectively doubles Radicle’s production footprint, significantly increasing its yearly capacity to 6,000 kilograms. “We are thrilled with the continued growth happening at Radicle,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “The cannabis industry is showing many similarities to the craft beer movement, where local, artisanal operators are succeeding in securing loyal and robust customer followings. Radicle is thriving within this craft segment, and is raising the bar when it comes to its unique strains offered under the Gage brand. We see no slowdown in consumer demand for premium products and brands, and this Health Canada approval will help Radicle better supply high quality craft cannabis to both the medical and adult-use markets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼